YU Hui-xia, YU Yun-xia, JI Wen-xia. Clinical Study of Tiaochong Pinggan Square on Treating 45 Cases of Menopausal Patients With Hypertension[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(21): 290-293.
DOI:
YU Hui-xia, YU Yun-xia, JI Wen-xia. Clinical Study of Tiaochong Pinggan Square on Treating 45 Cases of Menopausal Patients With Hypertension[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(21): 290-293. DOI: 10.11653/syfj2013210290.
Clinical Study of Tiaochong Pinggan Square on Treating 45 Cases of Menopausal Patients With Hypertension
Objective: The purpose is to study the curative effect of Tiaochong Pinggan square on hypertension of patients in perimenopausal period and its influence on vascular endothelial function and neuroendocrine function. Method: Ninety cases of hypertension patients in perimenopausal period were randomly divided into control group (45 cases) and observation group (45 cases) according to digital method. The patients in both groups took psychological supportive treatment. Patients in control group took the oryzanol tablets (20 mg/time
3 times/day) and felodipine zyban tablets (5 mg/time
1 time/day). Patients in observation group took Tiaochong Pinggan square
1 dose/day
2 times/day
conventional water frying. Treatment course was 8 weeks. Kupperman index (KI) was used to record symptoms of perimenopausal syndrome
detecting blood pressure levels of patients. Levels of serum estradiol (E2)
follicle-stimulating hormone (FSH)
luteinizing hormone (LH)
nitric oxide (NO)
endothelin 1 (ET-1)
neuropeptide Y (NPY)
neural antihypertensive peptides (NT) and β-endorphin (β-EP) were measured. Result: After treatment
in fourth week
levels of SBP and DBP in both groups reduced
compared to the state before treatment (P<0.01). In eighth week
levels of SBP and DBP in both groups fall further
observation group was lower than control group (P<0.01). The rate of blood pressure recover was 68.89%
superior to 46.67% in the control group (P<0.05). The effect of blood pressure efficacy of observation group was 93.33%
better than 73.33% of control group (P<0.05). In 4 weeks after treatment and the end of the treatment
KI score of the observation group was lower than the control group (P<0.01)
while the descend range of KI score in observation group was superior to the control group (P<0.01). After treatment
E2 level of observation group was higher than the control (P<0.05)
but levels of FSH and LH were lower than the control group (P<0.01). ET-1 level of observation group declined and was lower than the control group (P<0.01). However
NO level of observation group increased and was higher than the control group (P<0.01). NPY of observation group was lower than the control group after treatment
while levels of NT and β-EP were higher than the control group (P<0.05). Conclusion: On the basis of psychological guidance treatment
Tiaochong Pinggan square can improve clinical symptoms of patients with perimenopausal syndrome
decreasing blood pressure level of patients and promoting the patients' blood pressure return to normal state. Its mechanism may be related to its regulation of vascular endothelial function and neuroendocrine function
Clinical Effect of Yangyin Jiangya Capsule Combined with Jiangzhuo Quyu Granule in Treatment of Hypertension with Metabolic Syndrome
Expert Consensus on Clinical Diseases Responding Specifically to Traditional Chinese Medicine: Perimenopausal Syndrome
GRADE Clinical Study Evidence Evaluation and Expert Consensus on Antihypertensive Chinese Patent Medicines Combined with Western Medicines for Treatment of Hypertension
Biological Connotation of Disease-stage-state of Hypertension in Concept of State-target Differentiation and Treatment From Perspective of Lipophagy
Effect of Huatan Tongluo Prescription on Vulnerability of Carotid Atherosclerotic Plaque in Hypertension
Related Author
ZHANG Guo-rong
YI Xiao-hong
YIN Li-hong
ZHOU Yi-zhong
NIE Wei
HU Shiwan
LIANG Haiyan
MA Kun
Related Institution
China Association of Chinese Medicine
Institute of Metabolic Diseases,Guang'anmen Hospital,China Academy of Chinese Medical Sciences
Japan Friendship Hospital
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Beijing University of Chinese Medicine Third Affiliated Hospital